{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?houseId=2&answeringDeptId=17&uin=HL4532", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?houseId=2&answeringDeptId=17&uin=HL4532", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?houseId=2&answeringDeptId=17&uin=HL4532&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?_page=0&houseId=2&answeringDeptId=17&uin=HL4532", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?houseId=2&answeringDeptId=17&uin=HL4532", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?houseId=2&answeringDeptId=17&uin=HL4532", "items" : [{"_about" : "http://data.parliament.uk/resources/1717026", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1717026/answer", "answerText" : {"_value" : "
Whilst data for the past year is not yet available, the latest published data on radiotherapy costs is from the National Health Service national cost collection for 2021/22, where spend is reported as £550 million. More detailed data by the NHS trusts is also available at the NHS website, in an online only format.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4948", "label" : {"_value" : "Biography information for Lord Markham"} } , "answeringMemberPrinted" : {"_value" : "Lord Markham"} , "dateOfAnswer" : {"_value" : "2024-05-20", "_datatype" : "dateTime"} , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2024-05-20T15:05:30.797Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2024-05-09", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Radiotherapy: Expenditure"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask His Majesty's Government what was the total amount spent by the NHS on radiotherapy services in England in the past year, broken down by (1) region, and (2) NHS trust.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4130", "label" : {"_value" : "Biography information for Baroness Ritchie of Downpatrick"} } , "tablingMemberPrinted" : [{"_value" : "Baroness Ritchie of Downpatrick"} ], "uin" : "HL4532"} , {"_about" : "http://data.parliament.uk/resources/1195986", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"} ], "answer" : {"_about" : "http://data.parliament.uk/resources/1195986/answer", "answerText" : {"_value" : "
As part of our concerted national efforts, we will continue doing everything we can to ensure patients continue to access safe and effective medicines in all scenarios.<\/p>
It remains the Government\u2019s objective to negotiate a future relationship with the European Union before the end of the Transition Period and to make sure that patients reap the rewards. Both the United Kingdom and EU, in their published negotiating documents, have stated objectives to reach an agreement on trade in goods. The UK\u2019s published approach sets out how we want to facilitate trade in medicinal products such as diabetic medicines and medical radioisotopes and support high levels of patient safety.<\/p>
The Department will continue to work closely with the pharmaceutical industry, the National Health Service and others in the supply chain to help ensure patients can access the medicines they need, and precautions are in place to reduce the likelihood of future shortages.<\/p>"} , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4708", "label" : {"_value" : "Biography information for Lord Bethell"} } , "answeringMemberPrinted" : {"_value" : "Lord Bethell"} , "dateOfAnswer" : {"_value" : "2020-05-20", "_datatype" : "dateTime"} , "groupedQuestionUIN" : [{"_value" : "HL4533"} , {"_value" : "HL4534"} ], "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"} , "questionFirstAnswered" : [{"_value" : "2020-05-20T15:56:08.377Z", "_datatype" : "dateTime"} ]} , "answeringDeptId" : {"_value" : "17"} , "answeringDeptShortName" : {"_value" : "Health and Social Care"} , "answeringDeptSortName" : {"_value" : "Health and Social Care"} , "date" : {"_value" : "2020-05-14", "_datatype" : "dateTime"} , "hansardHeading" : {"_value" : "Diabetes: Drugs"} , "houseId" : {"_value" : "2"} , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"} } ], "questionText" : "To ask Her Majesty's Government what plans they have to ensure that diagnosed diabetics in the UK will have sufficient medication to prevent diabetic ketoacidosis, in the event that the UK leaves the transition period without a trade agreement with the EU on 31 December.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"} , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3691", "label" : {"_value" : "Biography information for Lord Roberts of Llandudno"} } , "tablingMemberPrinted" : [{"_value" : "Lord Roberts of Llandudno"} ], "uin" : "HL4532"} ], "itemsPerPage" : 10, "page" : 0, "startIndex" : 1, "totalResults" : 2, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]} }